UCLA Health builds an algorithm to help doctors pick semaglutide or resmetirom for MASH
The review weighs the two FDA-approved MASH drugs, which haven't been tested head to head, and notes some patients may do well on both.
Recap by typeshit. Full story at UCLA Health.